" /> Alectinib - CISMeF





Preferred Label : Alectinib;

NCIt synonyms : 5H-benzo(b)carbazole-3-carbonitrile, 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-(4-(4-morpholinyl)-1-piperidinyl)-11-oxo-; ALK Inhibitor RO5424802;

NCIt definition : An orally available inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with antineoplastic activity. Upon administration, alectinib binds to and inhibits ALK kinase, ALK fusion proteins as well as the gatekeeper mutation ALKL1196M known as one of the mechanisms of acquired resistance to small-molecule kinase inhibitors. The inhibition leads to disruption of ALK-mediated signaling and eventually inhibits tumor cell growth in ALK-overexpressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development. ALK dysregulation and gene rearrangements are associated with a series of tumors.;

UNII : LIJ4CT1Z3Y;

InChIKey : KDGFLJKFZUIJMX-UHFFFAOYSA-N;

CAS number : 1256580-46-7;

Drug name : Alecensa;

Molecule name : RO 5424802; AF-802; AF 802; RO-5424802; CH-5424802; CH 5424802; RG-7853; RG 7853;

ChEBI ID : CHEBI:62268;

Codes from synonyms : 16;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
31/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.